GO2EC.ORG
Site Map
About Us EC & Pharmacies State Information Legislation Media Center Resources Get Involved
Helping pharmacy & health communities improve access to Emergency Contraception (EC)

Update Us On News In Your State

Update/Add Contact Info

Update/Share Resources

Share Your Personal Story

Home > State Profiles > Colorado State Profile

Colorado State Profile

EC PHARMACY UPDATE

With the FDA's allowance of Plan B to be sold over-the-counter without a prescription to women 18 and older, Colorado Senator Betty Boyd (D) and Representative Anne McGihon (D) sponsored SB 60 during the 2007 legislative session to ensure sexual assault survivors receive information about the availability and use of EC. The bill was amended to require pharmacies that don't stock Plan B to notify customers that it is unavailable. The bill was signed into law by Gov. Bill Ritter Jr. on Mar. 15, 2007.

In previous legislative sessions, bills had been introduced to: allow pharmacies to dispense EC without a prescription (2006: HB 1212, vetoed by former Governor Owens); or to require emergency rooms to notify sex assault survivors of the availability and use of EC and to prescribe EC or for prescription (2005: HB 1042, vetoed by former Governor Owens; 2004: 1175, killed in committee; 2003: 1252, killed in committee).

Colorado pharmacists are not currently participating in any EC programs that provide service to the community.

NARAL Pro-Choice Colorado has researched access to and awareness of EC through health care providers and pharmacies. NARAL Pro-Choice Colorado surveyed hundreds of pharmacies in summer 2006 to create “The Emergency Contraception (EC) Resource Guide for Colorado,” a bilingual resource that features over 300 health care providers and pharmacies across the state that prescribe or fill prescriptions for EC. As part of its EC Education and Awareness Campaign, NARAL Pro-Choice Colorado held over 40 information sessions for about 900 attendees around EC and has distributed over 7,000 health care provider and pharmacy referral guides. For more information on their EC efforts and to receive fee copies of any of their publications, please go to www.prochoicecolorado.org.

For press coverage in this state, click here.

Back to top

CONTACTS

Val Kalnins, R.Ph.
Executive Director
Colorado Pharmacists Society
6825 E. Tennessee Ave. #440
Denver, CO 80224
303-756-3069
Fax: 303-756-3649
Val@copharm.org
www.copharm.org

Karen Forest, RN
San Juan Basin Health Department Family Planning Advisory Board
281 Sawyer Dr.
Durango, CO 81301
970-247-5702 x248
Fax: 970-247-9126
Karen@sjbhd.org

Laura B. Hansen, Pharm.D., FCCP, BCPS
Assistant Professor of Clinical Pharmacy and Family Medicine
University of Colorado at Denver and Health Sciences Center
4200 E. 9th Ave. Box C238
Denver, CO 80262
Phone: 303-315-3868
Fax: 303-315-4630

Toni Panetta
Deputy Director
NARAL Pro-Choice Colorado
303-394-1973
tpanetta@conaral.org
www.prochoicecolorado.org

Lenox Powell
Regional Public Affairs Coordinator
Planned Parenthood of the Rocky Mountains
3958 North Academy Blvd, Suite 108
Colorado Springs, CO 80917
719-573-8883
Fax: 719-573-8884
Lenox.Powell@pprm.org

Back to top

USEFUL LINKS

Colorado Board of Pharmacy
www.dora.state.co.us/pharmacy

Colorado Pharmacists Society
www.copharm.org

Colorado General Assembly
www.state.co.us/gov_dir/stateleg.html

Planned Parenthood of the Rocky Mountains
www.pprm.org/pprm/index.html

NARAL Pro-Choice Colorado
www.conaral.org

Back to top

PROTOCOL ENVIRONMENT

Possible Environment: Revision to Existing Authority Required

This state permits collaborative practice agreements or a similar agreement between physicians and pharmacists. However, some modification of existing statutes and/or regulations is required to allow pharmacists to initiate EC for the general community.

Pharmacist initiation of EC would require:

  • Modifying the requirement that pharmacists "administer" medications pursuant to a patient-specific order from a physician

Back to top

PHARMACY PRACTICE ACT

Pharmacy Practice Act Regulatory and Statutory Authority

Note: The text presented below has been prepared by the American Pharmacists Association for the Pharmacy Access Partnership and reflects legislation or regulation promulgated as of June 15, 2003.

COLORADO

Colorado has no statutory or regulatory authority under which pharmacists may enter into collaborative drug therapy agreements, and the law explicitly excludes “prescriptive authority” from the definition of pharmaceutical care.

“Qualified” pharmacists in any setting, however, may “administer” medications pursuant to a patient-specific order from a physician if the drug is for an outpatient, or pursuant to a “chart order” if it is for an in-patient in a hospital. There is no limit on the route of administration, nor any limitation on the eligible products that may be administered. The Board of Pharmacy reports that pharmacists are using this existing authority to administer immunizations. There are no specific requirements to report administration activity to the Board, nor does the statute define what determines if a pharmacist is “qualified” to administer medications, though prudence would suggest that a pharmacist have training in delivering injections prior to their administration.

Statutory authority: CO PracAct 12-22-102.

Regulatory authority: None applicable.

 

COLORADO STATUTE

CO PracAct 12-22-102.
Definitions.

As used in this part 1, unless the context otherwise requires:

(1)     “Administration” means the giving of medication to a patient by a pharmacist qualified to administer drugs by authorization of a physician.

***

(11)(a)  “Drug” means:

(I)  Substances recognized as drugs in the official United States Pharmacopoeia, national formulary, or the official homeopathic Pharmacopoeia of the United States, or any supplement to any of them;

(II) Substances intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in individuals or animals;

(III) Substances (other than food) intended to affect the structure or any function of the body of individuals or animals; and

(IV) Substances intended for use as a component of any substance specified in subparagraph (I), (II), or (III) of this paragraph (a).

(b)  “Drug” does not include devices or their components, parts, or accessories.

***

(22.5)     “Order” means:

(a) A prescription order which is any order, other than a chart order, authorizing the dispensing of a single drug or device that is written, mechanically produced, computer generated and signed by the practitioner, transmitted electronically or by facsimile, or by other means of communication by a practitioner and which includes the name or identification of the patient, the date, and sufficient information for compounding, dispensing, and labeling; or

(b) A chart order which is an order for inpatient drugs or medications to be dispensed by a pharmacist, or pharmacy intern under the direct supervision of a pharmacist, which is to be administered by an authorized person only during the patient's stay in a hospital facility.  It shall contain the name of the patient and of the medicine ordered and such directions as the practitioner may prescribe concerning strength, dosage, frequency, and route of administration.

***

(23.6)     “Pharmaceutical care” means the provision of drug therapy and other pharmaceutical patient care services by a pharmacist intended to achieve outcomes related to the cure or prevention of a disease, elimination or reduction of a patient's symptoms, or arresting or slowing of a disease process.  In addition to the preparation, dispensing, and distribution of medications, “pharmaceutical care” may include assessment and evaluation of the patient's medication related needs and development and communication of a therapeutic plan with defined outcomes in consultation with the patient and the patient's other health care professionals to attain the desired outcome.  This function includes efforts to prevent, detect, and resolve medication related problems for individual patients.  “Pharmaceutical care” does not include prescriptive authority.

***

(26)     “Practice of pharmacy” means:

(a) An initial interpretation, selection of ingredients and final evaluation of each prescription order or chart order, the participation in drug selection and drug utilization reviews, the participation in administration of drugs, the provision of pharmaceutical care including patient counseling and prospective drug review, drug and drug-related research not including prescriptive authority, the advising and providing of information concerning utilization of drugs and devices in the treatment of an injury and the treatment and prevention of disease, and the offering or performing of these health services, operations, or transactions necessary in the conduct, operation, and control of a prescription drug outlet by a pharmacist.

(b) The responsibility for the compounding, dispensing, labeling (except nonprescription drugs), delivery, storage, and distribution of drugs and devices and the maintenance of proper records thereof;

(c) (Deleted by amendment, L. 81, p. 696, 1.)

Back to top

The state comparison information above was adapted from a study conducted by the American Pharmacists Association and commissioned by the Pharmacy Access Partnership.

< Back to State Profiles

About UsEC & PharmaciesState ProfilesLegislationResourcesGet InvolvedHomeSite Map

© 2008 Pharmacy Access Partnership